Dermatology
News, opinions and meeting coverage in dermatology.
— Ritlecitinib led to 80% scalp coverage at 6 months in nearly a fourth of adolescents and adults
Latest in Dermatology
An 8-year-old-boy was brought to the doctor by his father for evaluation of painless facial lesions that were present for 3 weeks. Can you diagnose the patient?
Genetic testing helps identify this rare autosomal recessive genodermatosis
Here's how the medical team diagnosed and treated the rare inflammatory skin disorder
Unique randomization of 300,000 people in Wales suggests an association
Here's how the medical team diagnosed and treated the rare inflammatory skin disorder
Unique randomization of 300,000 people in Wales suggests an association
Dermatology Case Studies
Genetic testing helps identify this rare autosomal recessive genodermatosis
Here's how the medical team diagnosed and treated the rare inflammatory skin disorder
Is infection, injury, or diabetic dermopathy responsible?
More in Dermatology
New "points to consider" document lists early warning signs
Robust data from clinical trials, cohort studies still lacking
A mother brought her 7-year-old son to the doctor concerned about asymptomatic lesions that had developed on his knees over the past couple of weeks.
FDA's decision marks first approval for a redosable gene therapy
Trial sees success with single dose of prophylactic rifapentine for household contacts
Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input
Results will likely "encourage a practice change," editorialists say
S. aureus plays a role in the development of this common condition
Though used off-label for years, treatment isn't very beneficial
A 58-year-old man visited his doctor concerned about a painful rash that developed over his neck and chest earlier that day.
Also in TTHealthWatch: chronic pain in U.S. adults, and a new treatment for C. diff
"One of the highest tumor response rates we've seen in any cancer," study discussant says
Clinical implications apply to virtually all solid tumors and possibly hematologic malignancies
Dersimelagon significantly extended time to sun-related prodromal symptoms
